[1] |
ZHANG Chi, CHEN Jiahui, LIN Jinyi, WANG Yan, ZHANG Sijia, ZHU Wei, CHENG Leilei.
Validation of a scale for evaluating the cardiovascular risk after breast cancer therapy: the clinical scale for breast cancer treatment related cardiovascular toxicity
[J]. China Oncology, 2022, 32(1): 54-60.
|
[2] |
JIN Yizi, LIN Mingxi, ZHANG Jian.
Targeting DNA damage response deficiency in the treatment of breast cancer
[J]. China Oncology, 2022, 32(1): 61-67.
|
[3] |
Expert group of expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition) .
Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition)
[J]. China Oncology, 2022, 32(1): 80-89.
|
[4] |
ZHANG Xiaoyan , LI Qingxiang , LIU Yong , LI Hang , QIU Lijuan , FENG Xinran , TAN Liming .
A study on the correlation between HMGB1 and clinical characteristics and immune function in patients with breast cancer
[J]. China Oncology, 2021, 31(9): 783-788.
|
[5] |
CAO Ailing, CAO Zhe, ZHOU Jian.
Effects of docetaxel combined with thymosin α1 on number of Treg in immune microenvironment of rats with breast cancer and its mechanism
[J]. China Oncology, 2021, 31(9): 799-806.
|
[6] |
YAO Jia , LI Guanqiao , YANG Shiping , SU Huiluan .
Effect of hsa-miR-98-5p/DKK3 signal axis on biological behavior of breast cancer cells
[J]. China Oncology, 2021, 31(9): 807-816.
|
[7] |
CONG Binbin, WANG Yongsheng.
Treatment landscape and challenges of managing the hormone receptor-positive early breast cancer
[J]. China Oncology, 2021, 31(8): 689-696.
|
[8] |
ZHU Yihui, LI Ting, HU Xichun.
Clinical research progress and prospect of trastuzumab deruxtecan
[J]. China Oncology, 2021, 31(8): 754-761.
|
[9] |
DING Gaofeng, GUO Leiming, LU Yufei.
The relationship between expressions of HER2 and BRCA1 and radiotherapy sensitivity in breast cancer patients
[J]. China Oncology, 2021, 31(7): 589-595.
|
[10] |
JIN Youping, LI Luying, ZHOU Ping.
A study on the role of long non-coding RNA STMN1P2 in breast cancer and its mechanism
[J]. China Oncology, 2021, 31(7): 596-604.
|
[11] |
XIE Jinfang , CAO Chunyu , REN Xue , TIAN Jiajun , LÜ Yafeng , HUANG Xiaofei .
Effects of sulforaphane on epithelial-mesenchymal transition, proliferation and migration of mouse breast cancer 4T1 cells
[J]. China Oncology, 2021, 31(7): 605-615.
|
[12] |
ZENG Feng , LI Dan , SHAO Xinxin , ZHANG Nengying , CHEN Xinghan , CHENG Xiaoming .
Prognostic nomogram for elderly breast cancer patients with 1-2 positive nodes who underwent mastectomy and different axillary surgeries: a SEER-based study
[J]. China Oncology, 2021, 31(4): 323-329.
|
[13] |
WANG Chunjian , NIE Gang , MAO Yan .
The role of TRIP6 in breast cancer and its mechanism
[J]. China Oncology, 2021, 31(3): 161-169.
|
[14] |
HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang .
Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer
[J]. China Oncology, 2021, 31(3): 221-226.
|
[15] |
HOU Jing, CHENG Jigan, WANG Hua, WEI Na, NI Qing.
Preliminary study on synergistic effect of nifuroxazide and olaparib on growth inhibition in breast cancer cells
[J]. China Oncology, 2021, 31(12): 1168-1173.
|